Elanco Animal Health Incorporated Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Elanco Animal Health Incorporated (ELAN) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $10.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-02-24
- Elanco Animal Health Incorporated unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $10.00M.
- Elanco Animal Health Incorporated unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Elanco Animal Health Incorporated unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $1.00M, a 50.00% decline from fiscal 2020.
- Elanco Animal Health Incorporated unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2020 was $2.00M, a 100.00% increase from fiscal 2019.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month as first filed |
|---|---|---|
| 2025-12-31 | $10.00M 10-K · filed 2026-02-24 | |
| 2022-12-31 | $0.00 10-K · filed 2024-02-26 | |
| 2021-12-31 | $1.00M 10-K · filed 2024-02-26 | |
| 2020-12-31 | $2.00M 10-K · filed 2023-03-01 | $2.10M 10-K · filed 2021-03-01 |
| 2019-12-31 | $1.00M 10-K · filed 2022-02-28 | $1.20M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |